Aprea Therapeutics Inc. (APRE): APRE Chart and indicators looks ready fo...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	29
Posts	1427
Boards Moderated	0
Alias Born	11/15/2006

aristotelisonassis

Re: RockStarInvestor post# 16

Thursday, 01/21/2021 7:56:43 AM

Thursday, January 21, 2021 7:56:43 AM

APRE Chart and indicators looks ready for a huge upside move in the next days. Buying a starter position and watching closely.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APRE News

Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:01:02 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/05/2024 05:15:27 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:26:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:13:27 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/26/2024 11:03:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:16:01 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/09/2023 09:20:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:35 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 11:31:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:30:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:52:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:50:02 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:48:22 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 12:00:28 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:39:02 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:36:21 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/11/2023 11:30:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 08:01:07 PM
Aprea Therapeutics to Present at Maxim Virtual Healthcare Conference • GlobeNewswire Inc. • 06/14/2023 12:00:00 PM
Aprea Therapeutics to Present at BIO International Convention • GlobeNewswire Inc. • 05/30/2023 12:30:00 PM
Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations • GlobeNewswire Inc. • 05/15/2023 08:05:00 PM
Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors • GlobeNewswire Inc. • 05/08/2023 12:00:00 PM

More APRE News

InvestorsHub NewsWire

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover